Fertility

Organon Launches New Fertility Journey Website as Part of Ongoing Commitment to Help Address the Needs of Women

Friday, October 15, 2021 - 11:50am

The website aims to meet people wherever they are on their fertility journey and equip them with knowledge and questions for consideration to feel prepared and empowered throughout their journey.

Key Points: 
  • The website aims to meet people wherever they are on their fertility journey and equip them with knowledge and questions for consideration to feel prepared and empowered throughout their journey.
  • We want to provide support to anyone looking to start a family and for those accompanying them.
  • I am proud to work at Organon where we are truly devoted to understanding the journey.
  • Every fertility journey is a personal one, but many on this road have similar questions.

New Data Presented at ECTRIMS Show Evobrutinib is First BTK Inhibitor to Demonstrate a Significant Reduction in Slowly Expanding Lesions (SEL) in Patients with RMS

Thursday, October 14, 2021 - 4:00pm

Evobrutinib reduced SEL volume compared to placebo in a dose-dependent manner with the highest effect with 75mg twice daily (p=0.047).

Key Points: 
  • Evobrutinib reduced SEL volume compared to placebo in a dose-dependent manner with the highest effect with 75mg twice daily (p=0.047).
  • In a subgroup analysis, the effect of evobrutinib on SEL volume was also especially apparent in patients with more advanced disease.
  • These results, combined with the reduction in Gd+ lesions reported previously, suggest that evobrutinib reduces both acute and chronic neuroinflammation that together lead to worsening disability.
  • These initial findings across NfL data combined with SEL data continue to show evobrutinibs potential benefit in disease progression.

INVO Bioscience Announces Grand Opening of "Positib Fertility, an INVO Center" in Monterrey, Mexico on November 1, 2021

Thursday, October 14, 2021 - 2:00pm

This becomes the first INVO Center in Mexico and follows the recent openings of INVO Centers in Birmingham, Alabama and Atlanta, Georgia.

Key Points: 
  • This becomes the first INVO Center in Mexico and follows the recent openings of INVO Centers in Birmingham, Alabama and Atlanta, Georgia.
  • Positib Fertility, an INVO Center, is a partnership between INVO Bioscience and experienced reproductive specialist Dr. Francisco Arredondo, MD., MPH and Dr. Ramiro Ramirez Gutierrez, MD.
  • Dr. Arredondo successfully sold his U.S.-based fertility clinics in 2019 and is now focused on bringing the INVOcell solution to Mexico.
  • Steve Shum, CEO of INVO Bioscience, commented, "This is yet another milestone in the history of the Company and the INVOcell solution as we announce the grand opening of our first INVO Center in Mexico.

Advancements in reproductive medicine available at Shady Grove Fertility (SGF) can reduce the inheritance of genetic diseases like breast cancer

Thursday, October 14, 2021 - 1:45pm

Individuals and couples with known genetic diseases can turn to Shady Grove Fertility (SGF) to undergo in vitro fertilization (IVF) with preimplantation genetic testing for monogenic/single gene defects(PGT-M) to reduce the risk of passing genetic mutations to future offspring.

Key Points: 
  • Individuals and couples with known genetic diseases can turn to Shady Grove Fertility (SGF) to undergo in vitro fertilization (IVF) with preimplantation genetic testing for monogenic/single gene defects(PGT-M) to reduce the risk of passing genetic mutations to future offspring.
  • Additionally, patients at risk for dominant gene mutations, such as breast cancer or inherited forms of colon cancer, can have individualized testing for these diseases.
  • While Rose is not a carrier for the breast cancer gene, she is a carrier of a rare X-linked genetic mutation called Wiskott-Aldrich syndrome.
  • We are so fortunate to live in a world where we can now reduce the inheritance of deadly genetic diseases via IVF.

MassMutual Introduces New Employee Benefit to Help Pay Student Debt or Contribute to 529 College Saving Plans

Thursday, October 14, 2021 - 1:00pm

The program, which is flexible and voluntary, applies to any student loan debt in an employees name, including Parent PLUS loans.

Key Points: 
  • The program, which is flexible and voluntary, applies to any student loan debt in an employees name, including Parent PLUS loans.
  • Student debt can profoundly impact an individuals financial, social and emotional well-being, while also having far-reaching effects on the economy.
  • To explore career opportunities with MassMutual or to connect with a virtual job assistant, visit careers.MassMutual.com and follow MassMutual on LinkedIn .
  • MassMutual is a leading mutual life insurance company that is run for the benefit of its members and participating policyowners.

First Fertility Launches, Sets Stage for Growth

Tuesday, October 12, 2021 - 1:00pm

AVON, Connecticut, Oct. 12, 2021 (GLOBE NEWSWIRE) -- First Fertility, a leading fertility company focused on patient experience, has launched its brand with plans to accelerate growth nationwide.

Key Points: 
  • AVON, Connecticut, Oct. 12, 2021 (GLOBE NEWSWIRE) -- First Fertility, a leading fertility company focused on patient experience, has launched its brand with plans to accelerate growth nationwide.
  • "We are building a network of best-in-class IVF centers with the singular purpose of putting our patients first," commented Derek Larkin, CEO of First Fertility.
  • "Each of our investments and innovations will be focused on continually improving the experiences of our patients.
  • Now, as we grow with these strategic partnerships and acquisitions, First Fertility will bring positive and transformative opportunity for fertility care in the United States."

WINFertility Empowers Female Naval Aviators' Choice to Pursue Career and Family, in Partnership with Military Family Building Coalition

Tuesday, October 12, 2021 - 2:00pm

GREENWICH, Conn., Oct. 12, 2021 /PRNewswire-PRWeb/ -- WINFertility (WIN), the nation's leading fertility benefit management company with the largest portfolio of employer clients, empowers female Naval Aviators' choice to pursue career and family, in partnership with Military Family Building Coalition (MFBC) under the AVIATRIX Project.

Key Points: 
  • GREENWICH, Conn., Oct. 12, 2021 /PRNewswire-PRWeb/ -- WINFertility (WIN), the nation's leading fertility benefit management company with the largest portfolio of employer clients, empowers female Naval Aviators' choice to pursue career and family, in partnership with Military Family Building Coalition (MFBC) under the AVIATRIX Project.
  • If service members want to start a family, managed fertility benefit support can help retain talent and empower them with the option to pursue both career and family.
  • "The Military Family Building Coalition is very excited to collaborate with WINFertility in service to the women of naval aviation and in support of diversity within military leadership," said Katy Bell Hendrickson, Cofounder, Military Family Building Coalition.
  • The Military Family Building Coalition (MFBC) is a non-profit organization, dedicated to supporting active-duty military members with family building challenges.

CooperVision Launches New Myopia Education Campaign for U.S. Parents

Tuesday, October 12, 2021 - 1:00pm

SAN RAMON, Calif., Oct. 12, 2021 /PRNewswire/ -- CooperVision, a global leader in myopia management, today announced a new U.S. education initiative called "Take Control: Myopia & You" to increase awareness of the disease and encourage parents to schedule eye exams for their young children.

Key Points: 
  • SAN RAMON, Calif., Oct. 12, 2021 /PRNewswire/ -- CooperVision, a global leader in myopia management, today announced a new U.S. education initiative called "Take Control: Myopia & You" to increase awareness of the disease and encourage parents to schedule eye exams for their young children.
  • "Now we're encouraging additional parents to act by learning more and having these conversations with their eye doctor.
  • In addition to celebrity spokespeople, the omnichannel "Take Control: Myopia & You" campaign will feature notable eye care professionals.
  • 1 Holden et al, - Global Prevalence of myopia and high myopia and temporal trends from 2000 through 2050.

Shady Grove Fertility (SGF) expands egg donation program to Allentown, PA

Monday, October 11, 2021 - 1:10pm

ALLENTOWN, Pa., Oct. 11, 2021 /PRNewswire-PRWeb/ -- Shady Grove Fertility (SGF) , home to one of the largest egg donor programs in the country, now offers full-service egg donation intheir Allentown, PA , location.

Key Points: 
  • ALLENTOWN, Pa., Oct. 11, 2021 /PRNewswire-PRWeb/ -- Shady Grove Fertility (SGF) , home to one of the largest egg donor programs in the country, now offers full-service egg donation intheir Allentown, PA , location.
  • SGF recruits and medically, psychologically, and genetically prescreens all prospective, ready-to-cycle egg donors prior to listing them on the SGF donor registry .
  • Under SGF's stringent screening requirements, any prospective egg donor between the ages of 21-34 who is healthy and has knowledge of their family history may be considered for egg donation.
  • To learn more about becoming an egg donor at SGF including eligibility requirements, the donation process, compensation, and egg donation FAQS visit Become an Egg Donor , or complete your initial egg donor application .

Tolmar Establishes Tolmar Canada to Sell, Market and Distribute ELIGARD® in Canada

Friday, October 8, 2021 - 3:30pm

BUFFALO GROVE, Ill., Oct. 8, 2021 /PRNewswire/ -- Tolmar, a specialty pharmaceutical company, today announced that, effective January 1, 2022, the company will hold exclusive distribution rights to ELIGARD® (leuprolide acetate for injectable suspension) in Canada. ELIGARD® is a prescription medication for the palliative treatment of advanced prostate cancer.

Key Points: 
  • With the establishment of Tolmar Pharmaceuticals Canada, Tolmar will resume the rights to ELIGARD in the Canadian market.
  • Tolmar will exclusively market, sell, and distribute ELIGARD in Canada after those respective dates.
  • "We are excited to regain the sales and marketing rights for ELIGARDin Canada," said Anil D'souza, CEO of Tolmar Pharmaceuticals.
  • The establishment of Tolmar Pharmaceuticals Canada will allow Tolmar to continue to advance ELIGARDinto the future."